Merck & Co., Inc. (MRK)
124.53
+0.71
(+0.57%)
USD |
NYSE |
Feb 24, 13:23
Merck Market Cap : 309.09B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 205.20B |
| Biogen, Inc. | 28.86B |
| Regeneron Pharmaceuticals, Inc. | 82.21B |
| Cidara Therapeutics, Inc. | 6.962B |
| Moderna, Inc. | 19.95B |
Market Cap Related Metrics
| PE Ratio | 17.12 |
| PS Ratio | 4.804 |
| PEG Ratio | 2.130 |
| Price to Book Value | 5.961 |
| Price | 124.53 |
| Earnings Yield | 5.84% |
| PEGY Ratio | 1.602 |
| Operating PE Ratio | 11.67 |
| Normalized PE Ratio | 14.48 |